1977•British Journal of Clinical PharmacologyOpen access

The bronchodilator effect of NAB 365.

P. L. Kamburoff, F.J. Prime, O P Schmidt

Abstract

1. Dose response relationships for salbutamol and a new bronchodilator drug NAB 365 have been obtained in patients with reversible airways obstruction. These show that the latter is about one hundred times more potent than the former. 2. NAB 365 has a very long half-life. The implications of this are discussed.

Open-access reader

About this research paper

What this paper is about

Why it matters

OpenAlex reports 21 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Bronchodilator, Salbutamol, Bronchodilator Agents, Medicine, Anesthesia, Pharmacology, Drug, Asthma